Nurix Therapeutics, Inc.
NRIX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001549595
In the last 90 days, Nurix Therapeutics, Inc. insiders filed 0 open-market purchases and 9 sales; 211 institutions reported holding it in 13F filings for Q2 2026, worth $2.84B in total; ARK Invest is the only superinvestor holding it.
13F holders, Q4 2022
Institutional positions in Nurix Therapeutics, Inc. as of Dec 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 119
- +4 vs. Q3 2022
- Shares held
- 42.7M
- +280.5K (+0.7%) vs. Q3 2022
- Total value
- $468.6M
- −$83.8M (−15.2%) vs. Q3 2022
- New holders
- 17
- 46 more added
- Sold out
- 13
- 34 more reduced
3 institutions that held it in Q3 2022 haven't filed for Q4 2022 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q3 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting NRIX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 211 | $2.84B |
| Q1 2026 | 196 | $1.81B |
| Q4 2025 | 182 | $2.15B |
| Q3 2025 | 173 | $783.3M |
| Q2 2025 | 164 | $1.01B |
| Q1 2025 | 170 | $1.01B |
| Q4 2024 | 175 | $1.53B |
| Q3 2024 | 172 | $1.53B |
| Q2 2024 | 174 | $1.36B |
| Q1 2024 | 139 | $721.3M |
| Q4 2023 | 131 | $475.6M |
| Q3 2023 | 129 | $352.5M |
| Q2 2023 | 126 | $435.7M |
| Q1 2023 | 124 | $376.6M |
| Q4 2022 | 119 | $468.6M |
| Q3 2022 | 118 | $561.0M |
| Q2 2022 | 106 | $568.4M |
| Q1 2022 | 117 | $565.6M |
| Q4 2021 | 125 | $1.17B |
| Q3 2021 | 113 | $1.18B |
| Q2 2021 | 104 | $1.05B |
| Q1 2021 | 101 | $1.29B |
Institutions, Q4 2022
Shares, value and share of portfolio for each institution holding Nurix Therapeutics, Inc.; share changes are against Q3 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Dimensional Fund Advisors LP | 583,742 | $6.41M | 0.00% | +249,017+74.4% | Added |
| Goldman Sachs Group Inc | 621,648 | $6.83M | 0.00% | −203,431−24.7% | Reduced |
| Nuveen Asset Management, LLC | 690,365 | $7.58M | 0.00% | +137,709+24.9% | Added |
| Bank of America Corp | 721,539 | $7.92M | 0.00% | +591,198+453.6% | Added |
| Candriam Luxembourg S.C.A. | 850,575 | $9.34M | 0.06% | +25,000+3.0% | Added |
| Geode Capital Management, LLC | 894,216 | $9.82M | 0.00% | +77,754+9.5% | Added |
| Pictet Asset Management SA | 962,357 | $10.6M | 0.02% | −113,992−10.6% | Reduced |
| FMR LLC | 1,003,643 | $11.0M | 0.00% | −682,008−40.5% | Reduced |
| Boxer Capital, LLC | 1,224,892 | $13.4M | 0.72% | 00.0% | Unchanged |
| Bain Capital Life Sciences Investors, LLC | 1,822,883 | $20.0M | 2.24% | 00.0% | Unchanged |
| ARK Investment Management LLCSuperinvestorARK Invest | 1,988,254 | $21.8M | 0.19% | +701,732+54.5% | Added |
| Vanguard Group Inc | 2,202,605 | $24.2M | 0.00% | +41,739+1.9% | Added |
| Deep Track Capital, LP | 2,266,569 | $24.9M | 1.08% | +212,948+10.4% | Added |
| State Street Corp | 2,507,987 | $27.5M | 0.00% | +195,763+8.5% | Added |
| Wasatch Advisors Inc | 2,538,632 | $27.9M | 0.19% | −118,805−4.5% | Reduced |
| Redmile Group, LLC | 3,000,784 | $32.9M | 1.35% | −5,900−0.2% | Reduced |
| Price T Rowe Associates Inc | 3,253,736 | $35.7M | 0.01% | −352,616−9.8% | Reduced |
| Baker Bros. Advisors LP | 3,882,125 | $42.6M | 0.26% | 00.0% | Unchanged |
| BlackRock Inc. | 4,142,528 | $45.5M | 0.00% | +419,438+11.3% | Added |
| Soleus Capital Management, L.P. | 0 | $0 | 0.00% | −504,144−100.0% | Sold out |
| Cubist Systematic Strategies, LLC | 0 | $0 | 0.00% | −131,919−100.0% | Sold out |
| BNP Paribas Arbitrage, SA | 0 | $0 | 0.00% | −76,415−100.0% | Sold out |
| Voloridge Investment Management, LLC | 0 | $0 | 0.00% | −75,876−100.0% | Sold out |
| Jennison Associates LLC | 0 | $0 | 0.00% | −43,181−100.0% | Sold out |
| Standard Life Aberdeen plc | 0 | $0 | 0.00% | −30,537−100.0% | Sold out |
| ExodusPoint Capital Management, LP | 0 | $0 | 0.00% | −25,954−100.0% | Sold out |
| Balyasny Asset Management LLC | 0 | $0 | 0.00% | −15,930−100.0% | Sold out |
| Dynamic Technology Lab Private Ltd | 0 | $0 | 0.00% | −15,498−100.0% | Sold out |
| Victory Capital Management Inc | 0 | $0 | 0.00% | −11,305−100.0% | Sold out |
| EDBI Pte Ltd | 0 | $0 | 0.00% | −7,442−100.0% | Sold out |
| Advisor Group Holdings, Inc. | 0 | $0 | 0.00% | −1,000−100.0% | Sold out |
| Point72 Hong Kong Ltd | 0 | $0 | 0.00% | −19−100.0% | Sold out |
| Ponoi Management, LLC | – | – | – | – | Not filed |
| Ponoi II Management, LLC | – | – | – | – | Not filed |
| Wipfli Financial Advisors LLC, | – | – | – | – | Not filed |